These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 17368348)

  • 1. WHO working group on standardisation and control of acellular pertussis vaccines--report of a meeting held on 16-17 March 2006, St. Albans, United Kingdom.
    Xing DK; Corbel MJ; Dobbelaer R; Knezevic I
    Vaccine; 2007 Apr; 25(15):2749-57. PubMed ID: 17368348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modified intra-cerebral challenge assay for acellular pertussis vaccines: comparisons among whole cell and acellular vaccines.
    Gaines-Das R; Horiuchi Y; Zhang SM; Newland P; Kim Y; Corbel M; Xing D
    Vaccine; 2009 Nov; 27(49):6824-32. PubMed ID: 19765397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Collaborative study for the standardisation of the histamine sensitizing test in mice and the CHO cell-based assay for the residual toxicity testing of acellular pertussis vaccines.
    Xing D; Maes A; Behr-Gross ME; Costanzo A; Daas A; Buchheit KH
    Pharmeur Bio Sci Notes; 2010 Apr; 2010(1):51-63. PubMed ID: 20223190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WHO Working Group meeting on standardization of acellular pertussis vaccines: Potency assay Beijing, China, 7-9 November 2007.
    Knezevic I; Baca-Estrada M; Xing DK; Lei D;
    Vaccine; 2008 Jul; 26(32):3960-8. PubMed ID: 18514369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. WHO Expert Committee On Biological Standardization.
    World Health Organ Tech Rep Ser; 1998; 878():i-vi, 1-101. PubMed ID: 9731464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Swedish efficacy trial of acellular pertussis vaccines--update and time for reflection.
    Olin P
    Dev Biol Stand; 1991; 73():33-6. PubMed ID: 1778327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Key points for the development of mouse immunogenicity test as potency assay for acellular pertussis vaccines.
    André M; Poirier B; Bornstein N; Marmonier D; El Zaouk A; Fuchs F
    Biologicals; 2000 Dec; 28(4):217-25. PubMed ID: 11237357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Verification of components of acellular pertussis vaccines that have been distributed solely, been in routine use for the last two decades and contributed greatly to control of pertussis in Japan.
    Kuno-Sakai H; Kimura M; Watanabe H
    Biologicals; 2004 Mar; 32(1):29-35. PubMed ID: 15026023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indications for acellular pertussis vaccines in adults: the case for selective, rather than universal, recommendations.
    Gardner P
    Clin Infect Dis; 1999 Jun; 28 Suppl 2():S131-5. PubMed ID: 10447031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Laboratory assessment problems of the efficacy of acellular pertussis vaccines].
    Gzyl A
    Przegl Epidemiol; 2004; 58(2):361-7. PubMed ID: 15517817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WHO Working Group on the standardisation and control of pertussis vaccines-report of a meeting held on 6-7 May 2003, Ferney Voltaire, France.
    Corbel MJ; Kreeftenberg JG; Knezevic I
    Vaccine; 2004 Jan; 22(3-4):293-300. PubMed ID: 14670307
    [No Abstract]   [Full Text] [Related]  

  • 12. A population-based, postlicensure evaluation of the safety of a combination diphtheria, tetanus, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine in a large managed care organization.
    Zangwill KM; Eriksen E; Lee M; Lee J; Marcy SM; Friedland LR; Weston W; Howe B; Ward JI
    Pediatrics; 2008 Dec; 122(6):e1179-85. PubMed ID: 19047220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acellular pertussis vaccines in China.
    Wang L; Lei D; Zhang S
    Vaccine; 2012 Nov; 30(50):7174-8. PubMed ID: 23084855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developments in pertussis vaccines: memorandum from a WHO meeting.
    Griffiths E; Kreeftenberg JG
    Bull World Health Organ; 1985; 63(2):241-8. PubMed ID: 3874713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overview of recent clinical trials of acellular pertussis vaccines.
    Miller E
    Biologicals; 1999 Jun; 27(2):79-86. PubMed ID: 10600188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-time polymerase chain reaction detection of Bordetella pertussis DNA in acellular pertussis vaccines.
    Tatti KM; Slade B; Patel M; Messonnier N; Jackson T; Kirkland KB; Talbot EA; Tondella ML
    Pediatr Infect Dis J; 2008 Jan; 27(1):73-4. PubMed ID: 18162945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Composition of acellular pertussis and combination vaccines: a general review.
    Jadhav SS; Gairola S
    Biologicals; 1999 Jun; 27(2):105-10. PubMed ID: 10600195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acellular pertussis vaccines in Japan: past, present and future.
    Watanabe M; Nagai M
    Expert Rev Vaccines; 2005 Apr; 4(2):173-84. PubMed ID: 15889991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole-cell and acellular pertussis vaccination programs and rates of pertussis among infants and young children.
    Vickers D; Ross AG; Mainar-Jaime RC; Neudorf C; Shah S
    CMAJ; 2006 Nov; 175(10):1213-7. PubMed ID: 17098950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of acellular pertussis vaccines-induced immunity against infection due to Bordetella pertussis variant isolates in a mouse model.
    Denoël P; Godfroid F; Guiso N; Hallander H; Poolman J
    Vaccine; 2005 Nov; 23(46-47):5333-41. PubMed ID: 16054273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.